| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/12/2013 | US20130236469 Vaccine against streptococcal infections based on recombinant proteins |
| 09/12/2013 | US20130236458 Dual specific binding proteins directed against il-13 and/or il-17 |
| 09/12/2013 | US20130236457 Compositions and Methods Relating to Anti-IGF-1 Receptor Antibodies |
| 09/12/2013 | US20130236454 Superior efficacy of cd37 antibodies in cll blood samples |
| 09/12/2013 | US20130236452 Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof |
| 09/12/2013 | US20130236449 Methods of enhancing antibody-dependent cellular cytotoxicity |
| 09/12/2013 | US20130236448 Concentrated polypeptide formulations with reduced viscosity |
| 09/12/2013 | US20130236419 Compositions and methods related to attenuated staphylococcal strains |
| 09/12/2013 | US20130236418 Immunomodulatory Methods and Systems for Treatment and/or Prevention of Aneurysms |
| 09/11/2013 | EP2636736A1 Novel anti-dr5 antibody |
| 09/11/2013 | EP2636735A1 Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
| 09/11/2013 | EP2636682A1 Compositions comprising secretory-like immunoglobulins |
| 09/11/2013 | EP2636413A1 Chimeric virus-like particles (VLP) containing functional hMPV proteins |
| 09/11/2013 | EP2635694A2 Dual variable domain immunoglobulins and uses thereof |
| 09/11/2013 | EP2635607A1 Stable heterodimeric antibody design with mutations in the fc domain |
| 09/11/2013 | EP2635606A1 Mmp8 inactivating antigen binding proteins |
| 09/11/2013 | EP2635605A1 Anti-her3 antibodies and compositions |
| 09/11/2013 | EP2635604A2 Pan-her antibody composition |
| 09/11/2013 | EP2635603A1 C-met antibody combinations |
| 09/11/2013 | EP2635602A1 Anti c-met antibodies |
| 09/11/2013 | EP2635593A1 Vaccines for preventing meningococcal infections |
| 09/11/2013 | EP2635585A1 High-efficiency catalysts, preparation and use thereof |
| 09/11/2013 | EP2635579A1 Synthetic lethality in cancer |
| 09/11/2013 | EP2635305A1 Enhancement of pathogen-specific memory th17 cell responses |
| 09/11/2013 | EP2635304A2 Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
| 09/11/2013 | EP2635303A2 Methods of treating rheumatoid arthritis using il-17 antagonists |
| 09/11/2013 | EP2635302A1 Method for improving the production of influenza viruses and vaccine seeds |
| 09/11/2013 | EP2635301A1 Cytotoxic agents comprising new ansamitocin derivatives |
| 09/11/2013 | EP2635300A1 Dock-and-lock (dnl) constructs for human immunodeficiency virus (hiv) therapy |
| 09/11/2013 | EP2635299A2 Methods for treating hair loss disorders |
| 09/11/2013 | EP2635298A2 Antivenom |
| 09/11/2013 | EP2635294A1 Immunotherapy against erbb-3 receptor |
| 09/11/2013 | EP2635283A2 Methods for treatment of brain injury utilizing biologics |
| 09/11/2013 | EP2635257A2 RABIES GLYCOPROTEIN VIRUS-LIKE PARTICLES (VLPs) |
| 09/11/2013 | CN1842603B Method of selecting wt1 vaccine adaptive patient |
| 09/11/2013 | CN1678345B Multi plasmid system for the production of influenza virus |
| 09/11/2013 | CN103298937A Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor VIII |
| 09/11/2013 | CN103298936A Recombinant vaccinia virus having hemagglutinin protein genes derived from novel influenza viruses |
| 09/11/2013 | CN103298835A Method to inhibit recruitment of monocytes and macrophages by an ICAM-3 inhibitor |
| 09/11/2013 | CN103298834A Dual variable domain immunoglobulins and uses thereof |
| 09/11/2013 | CN103298832A ACTRIIA binding agents and uses thereof |
| 09/11/2013 | CN103298831A NK cell modulating treatments and methods for treatment of hematological malignancies |
| 09/11/2013 | CN103298490A Antibodies to notum pectinacetylesterase |
| 09/11/2013 | CN103298489A Novel EGFR-binding molecules and immunoconjugates thereof |
| 09/11/2013 | CN103298488A Peptide or peptide complex binding to 2 integrin and methods and uses involving the same |
| 09/11/2013 | CN103298487A Companion animal treatments |
| 09/11/2013 | CN103298486A Extraneous agents testing |
| 09/11/2013 | CN103298485A Multivalent vaccine for filariasis |
| 09/11/2013 | CN103298484A Improved vaccine compositions |
| 09/11/2013 | CN103290101A Ago2 gene and application of expression product thereof |
| 09/11/2013 | CN103289986A Cattle Brucella recombination strain S19-delta bp 26-BL and preparation method and application thereof |
| 09/11/2013 | CN103289966A Low virulent strain of pig Japanese encephalitis virus |
| 09/11/2013 | CN103289957A Methods and kit for preparing stem cell-like lung cancer cells and loading dendritic cells on antigen composition thereof |
| 09/11/2013 | CN103288973A Isatis root polysaccharides, and preparation method and use thereof |
| 09/11/2013 | CN103288958A A single chain antibody against a cancer stem cell-specific protein CD44 and applications thereof |
| 09/11/2013 | CN103288956A A camelized human anti-TNF-alpha genetically engineered antibody TsdAb40 and a preparation method and applications thereof |
| 09/11/2013 | CN103288936A Human homology-removed streptococcus pneumococcal surface protein A as well as purification method and application thereof |
| 09/11/2013 | CN103288934A Haemophilus parasuis immunoprotective antigen HbpA |
| 09/11/2013 | CN103288933A Haemophilus parasuis immunoprotective antigen CdtC |
| 09/11/2013 | CN103288931A Immunogenic polypeptides for human papillomavirus as well as preparation method and application of same |
| 09/11/2013 | CN103288920A Survivin-derived peptide and use thereof |
| 09/11/2013 | CN103285399A Freezing and drying protecting agent for amyxis brucella live vaccine |
| 09/11/2013 | CN103285393A Egg yolk antibody microcapsule for resisting hand-foot-and-mouth disease, and preparation method thereof |
| 09/11/2013 | CN103285392A Compositions for cancer immunotherapy and use thereof |
| 09/11/2013 | CN103285391A Combined vaccine of seasonal influenza and pandemic influenza for people and preparation method |
| 09/11/2013 | CN103285390A Method for preparing rabies vaccine |
| 09/11/2013 | CN103285389A Application of influenza vaccine in preparation of drugs for treating allergic diseases and allergy-related diseases |
| 09/11/2013 | CN103285388A Application of influenza vaccine in preparation of drugs for treating allergic diseases and allergy-related diseases |
| 09/11/2013 | CN103285387A PCV2 immunogenic compositions and methods of producing such compositions |
| 09/11/2013 | CN103285386A Immunisation method against 4 dengue serotypes |
| 09/11/2013 | CN103285385A Method for preparing porcine circovirus 2-type inactivated vaccine |
| 09/11/2013 | CN103285384A Application of large granular leukocyte (LGL) protein of schistosoma japonicum katsurada |
| 09/11/2013 | CN102746398B Single-chain antibody ZL1 against chicken-derived Newcastle disease virus P protein, preparation method and application thereof |
| 09/11/2013 | CN102504023B Method for preparing egg yolk antibody, egg yolk antibody prepared by method and application of egg yolk antibody |
| 09/11/2013 | CN102296089B Method for efficiently preparing porcine circovirus 2 type empty capsid |
| 09/11/2013 | CN102264393B Anti-hcv monoclonal antibody as a medicament for the therapeutic treatment and prevention of hcv infections |
| 09/11/2013 | CN102000327B Mink viral enteritis inactivated vaccine and preparation method thereof |
| 09/11/2013 | CN101961488B Method for preparing serum for resisting Muscovy duck parvovrius |
| 09/11/2013 | CN101918841B Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 09/11/2013 | CN101716342B New castle disease and infectious bronchitis integrated inactivated vaccine and manufacture method thereof |
| 09/11/2013 | CN101695573B Method for producing pseudorabies living vaccines by using subculture cell source and product thereof |
| 09/11/2013 | CN101688194B Detoxified pneumococcal neuraminidase and uses thereof |
| 09/11/2013 | CN101686971B Methods of treating multiple myeloma using combination therapies based on anti-cs1 antibodies |
| 09/11/2013 | CN101525385B Screening and preparation method and application for antibody medicament for malignant lymphoma and autoimmune diseases |
| 09/10/2013 | US8530627 FcγRIIB specific antibodies and methods of use thereof |
| 09/10/2013 | US8530430 TTK peptides and vaccines including the same |
| 09/10/2013 | US8530421 Isolated polypeptides used for treatment of inflammatory diseases and inhibiting cancer metastasis |
| 09/10/2013 | US8530414 Antibodies to PCSK9 and uses thereof |
| 09/10/2013 | US8530410 Method for treating a keloid with a botulinum toxin |
| 09/10/2013 | US8530408 Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate |
| 09/10/2013 | US8530234 Hepatitis C virus vaccine |
| 09/10/2013 | US8530225 Therapeutic agents comprising pro-apoptotic proteins |
| 09/10/2013 | US8530189 Sustained drug delivery system |
| 09/10/2013 | US8529939 Purified protein(s) combined with drug(s) and biocompatible solvent(s) to form a coatable mixture; reduction to form a cohesive body or solidified cohesive mass that is formed into a mucoadhesive device havinghomogenous distribution; ovalbumin combined with glycerol; bonding strength |
| 09/10/2013 | US8529913 Immunogenic compositions for Streptococcus pyogenes |
| 09/10/2013 | US8529912 Group B Streptococcus polypeptides, nucleic acids and therapeutic compositions and vaccines thereof |
| 09/10/2013 | US8529911 Small Streptococcus pyogenes antigens and their use |
| 09/10/2013 | US8529910 Enterococcus antigens |
| 09/10/2013 | US8529909 Method for the production and purification of bovine leukemia virus GP51 surface glycoprotein in the absence of bovine serum |
| 09/10/2013 | US8529908 Meningococcal conjugate vaccination |